For families facing a childhood cancer diagnosis, access to personalized, trustworthy guidance on how to best treat their child’s illness is paramount. Mayo Clinic Laboratories’ testing for childhood malignancy is designed by pediatric oncology experts to evaluate targetable mutations for individualized insights that can confirm diagnosis and guide treatment selection.
1 in 8
1 in 8 patients have a germline variant1
50+ hereditary cancer syndromes have been described2
33% of patients identified to have germline variants benefit from tailored cancer treatment3
Fill out the form below and one of our specialists will be in touch.